Seven Eight Capital’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Seven Eight Capital’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-7,100	Closed	-$447K	–	603
2020 Q1	$447K	Buy	+7,100	New	+$638K	0.11%	236
2018 Q4	–	Sell	-4,719	Closed	-$596K	–	748
2018 Q3	$596K	Buy	+4,719	New	+$499K	0.04%	427
2018 Q1	–	Sell	-6,363	Closed	-$372K	–	571
2017 Q4	$372K	Sell	6,363 -84,024	-93%	-$5.3M	0.04%	358
2017 Q3	$5.25M	Buy	+90,387	New	+$9.74M	0.64%	37
2014 Q4	–	Sell	-1,100	Closed	-$260K	–	690
2014 Q3	$260K	Buy	1,100 +500	+83%	+$127K	0.2%	179
2014 Q2	$142K	Buy	+600	New	+$158K	0.14%	241

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Seven Eight Capital's ICPT Position: Q2 2020 in Review

Seven Eight Capital sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2020, closing a stake of 7,100 shares — an estimated $447K sold.

Seven Eight Capital first reported a position in ICPT in Q2 2014 and held it in 6 quarters. The position peaked at $5.25M in Q3 2017. 192 funds tracked by Wall St. Rank hold ICPT as of Q2 2020.

Seven Eight Capital reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
Seven Eight Capital sold 7,100 Intercept Pharmaceuticals, Inc. shares in Q2 2020, an estimated $447K.
Seven Eight Capital first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2014 and held it in 6 quarters.
Seven Eight Capital's Intercept Pharmaceuticals, Inc. position peaked at $5.25M in Q3 2017.
192 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2020.

Based on Seven Eight Capital's 13F filing for Q2 2020, filed 6 Aug 2020.